Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBIT Margin (2024)

Incannex Healthcare's EBIT Margin history spans 1 years, with the latest figure at 41700.0% for Q4 2024.

  • On a quarterly basis, EBIT Margin changed N/A to 41700.0% in Q4 2024 year-over-year; TTM through Jun 2025 was 27661.63%, a N/A change, with the full-year FY2025 number at 27661.63%, up 22268004.0% from a year prior.
  • EBIT Margin hit 41700.0% in Q4 2024 for Incannex Healthcare, down from 8451.35% in the prior quarter.
  • Over the last five years, EBIT Margin for IXHL hit a ceiling of 8451.35% in Q3 2024 and a floor of 41700.0% in Q4 2024.